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Abstract
The causative agent of anthrax, Bacillus anthracis, is capable of circumventing the humoral and innate immune defense of
the host and modulating the blood chemistry in circulation to initiate a productive infection. It has been shown that the
pathogen employs a number of strategies against immune cells using secreted pathogenic factors such as toxins. However,
interference of B. anthracis with the innate immune system through specific interaction of the spore surface with host
proteins such as the complement system has heretofore attracted little attention. In order to assess the mechanisms by
which B. anthracis evades the defense system, we employed a proteomic analysis to identify human serum proteins
interacting with B. anthracis spores, and found that plasminogen (PLG) is a major surface-bound protein. PLG efficiently
bound to spores in a lysine- and exosporium-dependent manner. We identified a-enolase and elongation factor tu as PLG
receptors. PLG-bound spores were capable of exhibiting anti-opsonic properties by cleaving C3b molecules in vitro and in
rabbit bronchoalveolar lavage fluid, resulting in a decrease in macrophage phagocytosis. Our findings represent a step
forward in understanding the mechanisms involved in the evasion of innate immunity by B. anthracis through recruitment
of PLG resulting in the enhancement of anti-complement and anti-opsonization properties of the pathogen.
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Introduction
Bacillus anthracis, the causative organism of anthrax, is a spore-
forming Gram-positive bacterium. Infection can be initiated by the
spores through inhalation, ingestion, or cutaneous abrasions. In
inhalational infection, alveolar macrophages phagocytose the
spores deposited on the lung surface and deliver them to the
regional lymph nodes. In spite of the bactericidal activity of
macrophages, some of the engulfed spores survive, germinate into
vegetative bacteria, kill the macrophage, and subsequently become
released into the lymphatic system. Further growth of the bacteria
leads to the hemorrhagic lymphadenitis, allowing the pathogen to
break into the bloodstream and spread systemically through the
circulation [1,2].
In order to initiate a productive infection, B. anthracis needs to
circumvent the innate protective response of the host. It has been
shown that the pathogen employs a number of strategies against the
immune cells using secreted pathogenic factors. For example, lethal
and edema toxins secreted alongwithother virulencefactorssuch as
hemolysins within the phagosomal compartment of macrophages
allow the bacteria to resist being killed and to escape from the
phagocytes [3]. Cleavage of mitogen-activated protein kinase
kinases by lethal toxin seems to play a central role in the
immunosuppressive capacity of B. anthracis to induce necrosis or
apoptosis of macrophages [4] and to inhibit responses of dendritic
and T cells [5–7]. The pore-forming hemolysin anthrolysin O is
able to damage membranes of different immune cell types and to
sensitize macrophages to lethal toxin [8]. However, interference of
B. anthracis with the innate immune system through specific
interaction of the spore surface with the host proteins such as the
complement system has heretofore attracted little attention.
The complement system facilitates bactericidal activity of
normal human serum (NHS) in early clearance of pathogens
[9,10]. The complement system can be activated through three
different pathways: classical, lectin, and alternative. Deposition of
complement C3b onto the bacterial surface is a crucial step in
eliminating the pathogen. To escape complement-mediated
killing, pathogens use a common evasion strategy by acquiring
the fluid-phase complement factor H, complement factor H-
related proteins (FHRs), complement factor H-like proteins
(FHLs), the complement C4-binding protein from host serum
[10,11]. It has also been observed that B. anthracis can directly
infect non-phagocytic cells [12] and invade tissues of the
nasopharynx after spore inhalation without needing to be
transported by alveolar macrophages to the lymphatics [13].
A number of pathogens bind host zymogen protease plasmin-
ogen (PLG) to the bacterial surface for tissue invasion [14]. PLG is
an abundant protein found in the plasma and is a central
component of the fibrinolytic system. Activation of the fibrinolytic
system by PLG has recently been found during B. anthracis
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active plasmin by host-expressed tissue-type PLG activator (tPA)
and urokinase (uPA). PLG activation to plasmin by invasive
pathogenic bacteria such as Borrelia burgdorferi [16] or Pseudomonas
aeruginosa [17] could substantially augment the organism’s potential
for tissue invasion and necrosis. However, B. anthracis protease
InhA can accelerate the uPA-mediated plasminogen activation,
thereby suggesting a mechanism of plasmin modulation in anthrax
infection [15]. As a component of the exosporium [18], this
protease might be relevant to the invasive properties of the spores.
The active plasmin is a broad-spectrum serine protease that
dominantly degrades non-collagenous extracellular matrix (ECM)
and basal membrane proteins such as laminin and fibronectin
[19]. A recent study also showed that plasmin bound to the
borrelial surface leads to a drastic decrease in C3b deposition,
suggesting that plasmin has anti-opsonic properties [16].
Since functional complement proteins are present in the
bronchoalveolar lavage fluid (BALF) [20], complement C3-
dependent opsonization is expected to play an important role in
the early stages of inhalational B. anthracis infection. In fact, C3b can
bind to B. anthracis spores opsonized by the normal human serum
(NHS)andthusenhancephagocytosisbyhumanmacrophages[21].
Complement-deficient A/J mice are highly susceptible to the
attenuated B. anthracis Sterne strain [22], and the resistant C57BL/6
mice acquire susceptibility to challenge with the attenuated Sterne
strain after depletion of complement by cobra venom injection [23].
The above considerations prompted us to investigate the
proteome of NHS bound to B. anthracis spores. Here we provide
evidence that PLG binds B. anthracis through surface a-enolase and
elongation factor-tu, and its activation to plasmin by uPA results in
a reduction in C3b/iC3b deposition in spores. Recent studies
suggested that bacterial surface proteins a–enolase and glyceral-
dehyde-3-phasphate dehydrogenase of B. anthracis bound PLG
[24,25]. Together with the results, our findings represent a step
forward in understanding the mechanisms involved in B. anthracis
resistance to complement attack and opsonization resulting in the
increased ability of the pathogen to invade the host.
Materials and Methods
Bacterial strains and reagents
B. anthracis non-encapsulated Sterne strain 34F2 [pXO1
+,
pXO2
2] was obtained from the Colorado Serum Company.
Non-virulent B. subtilis 168 was purchased from the American
Type Culture Collection (Manassas, VA, USA). Human PLG,
plasmin, rabbit anti-GroEL polyclonal antibody, and D-Val-Leu-
Lys-p-nitroanilide (VLK-pNA, Sigma V7127) were purchased
from Sigma. Human complement C3b (product # 204860) and
uPA (product # 672112) were purchased from Calbiochem, and
rabbit anti-human C3c polyclonal antibody (product # A0062)
was from Dako. NHS was obtained from Innovative and goat anti-
human PLG polyclonal antibody (ab6189) and rabbit anti-mouse
C3 polyclonal antibody (ab11887) from Abcam. Mouse monoclo-
nal antibody (EF12) against an abundant B. anthracis exosporium
protein BclA (1 mg/ml; used 1:1,000 dilution for Western blot)
[26] was kindly provided by J.F. Kearney (University of Alabama).
Horse raddish peroxidase (HRP)-conjugated secondary antibodies
sheep anti-mouse IgG and donkey anti-rabbit IgG antibody were
purchased from GE Healthcare and rabbit anti-goat IgG antibody
from Jackson Immuno Research.
PLG binding onto B. anthracis
1.6610
9 spores or 100 ml of vegetative cells grown to A600 of 1.5
were incubated with 150 ml of NHS or 10 mg of purified PLG in
binding buffer (50 mM Tris, pH 7.5, 100 mM NaCl, and 2 mM
MgCl2) for 1 h at room temperature on a rocker platform and
then washed 4 times with binding buffer. The 5
th wash in 100 mlo f
binding buffer was saved as a wash control, and bound proteins
were eluted with 100 ml of 3 M potassium thiocyanate. The eluted
protein was separated by SDS-PAGE and analyzed by Western
blot with anti-PLG. To examine the effects of amino acids on PLG
binding to the pathogen surface, 5610
7 Sterne spores in binding
buffer were incubated with 2 mg of PLG and 50 mM amino acids
for 1 h on a rocker platform. The spores were washed 2 times with
1 ml of binding buffer and incubated in 150 ml of 50 mM Tris-
HCl, pH 7.5, complemented with 20 units (0.2 ug) of uPA and
150 ml of 200 mM VLK-pNA for 15 min at 37uC. Plasmin activity
was measured by reading absorbance of 100 ml of reactants at
405 nm. The spores were suspended in 150 ml of binding buffer
and incubated with 4 mg of PLG for 1 h. After 5 washings with
150 ml of the binding buffer, the spores were suspended in 300 ml
of 50 mM Tris-HCl, pH 7.5, and incubated with 20 units of uPA
and substrate. Plasmin activity was measured as described above.
Two-Dimensional SDS-PAGE
Spore-bound NHS proteins were eluted by a chaotropic
reagent, potassium thiocyanate, as described above and dialyzed
in water. Samples were subjected to two-dimensional (2D)
electrophoresis as follows: the desalted proteins were dissolved in
Zoom 2D protein solubilizer-1 and applied on immobilized pH 3–
10 linear gradient strips according to the manufacturer’s
instructions (Invitrogen). Focusing started at 175 V (15 min), was
ramped to 2000 V for 45 min, and finally continued at 2000 V for
30 min in an IPGrunner system (Invitrogen). After focusing, strips
were equilibrated for sample buffer and then overlaid onto 4–12%
SDS-PAGE. The separated proteins were silver-stained and the
bands were excised from the stained gel.
Mass spectrometry
The potassium thiocyanate-eluted spore-bound proteins or
silver-stained protein bands excised from the 2D gel were
trypsinized as described [15]. Identification of the proteins was
performed by LTQ-tandem MS/MS equipped with a reverse-
phase liquid chromatography nanospray tandem MS using a high-
resolution LTQ-Orbitrap spectrometer (ThermoFisher). The
reverse-phase column was slurry-packed in house with 5 mm,
200-A ˚ pore size C18 resin (Michrom BioResources) in a
100 mm610 cm fused silica capillary (Polymicro Technologies)
with a laser-pulled tip. After sample injection, the column was
washed for 5 min at 200 nl/min with 0.1% formic acid, peptides
were eluted using a 50-min linear gradient from 0 to 40%
acetonitrile and an additional step of 80% acetonitrile (all in 0.1%
formic acid) for 5 min. The LTQ-Orbitrap MS was operated in a
data-dependent mode in which each full MS scan was followed by
five MS-MS scans where the five most abundant molecular ions
were dynamically selected and fragmented by collision-induced
dissociation using normalized collision energy of 35%. Tandem
mass spectra were matched against the National Center for
Biotechnology Information mouse database by Sequest Bioworks
software (ThermoFisher) using full tryptic cleavage constraints and
static cysteine alkylation by iodoacetamide. For a peptide to be
considered legitimately identified, it had to be the top number one
matched and had to achieve cross-correlation scores of 1.9 for
[M+H]
1+, 2.2 for [M+2H]
2+, 3.5 for [M+3H]
3+, DCn.0.1, and a
maximum probability of randomized identification of 0.01. The
MS data were filtered to improve the quality of the data set prior
to protein selection. The initial set of proteins was limited to those
Innate Immune Evasion of B. anthracis
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remove proteins with few non-zero peptide hits.
Preparation of recombinant proteins
The target genes of B. anthracis were amplified from its
chromosomal DNA by PCR with specific oligonucleotides using a
Taq polymerase premix (Invitrogen). Primers used in this study were
as follows: GroEL (BA0267), forward GCA AAA GAT ATT AAA
TTT AGT GAA, reverse CAT CAT TCC GCC CAT ACC GCC;
enolase (BA5364), forward ATG TCAACA ATTATT GAT GTT,
reverse TCA TCG TTT GAT GTT ATA AAA; and EF-tu
(BA0108), forward ATG GCT AAA GCT AAA TTC GAA, reverse
TCA CTC AAC GAT AGT AGC AAC. The amplicons were
ligated into expression plasmid pTrcHis2-TOPO (Invitrogen) and
then transformed into E. coli DH5a following the manufacturer’s
instructions. Protein expression was induced with 1 mM isopropyl-
b-D-thiogalactoside for 5 h.The 66His-tagged fusion proteins were
isolated under native conditions by Ni
2+-NTA resin (Probond,
Invitrogen)asdescribed inthemanufacturer’sprotocols. For binding
assays, purified proteins (320 mg) were also conjugated to carbox-
ylate-modified FluoSpheres (1.0 mm, 500 ml) in the presence of
EDAC (1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide) according
to the manufacturer’s recommendations (Invitrogen). The resulting
beadswereblocked with1%BSAand resuspendedin500 mlofPB S.
Exosporium extraction and ligand blot analysis
Exosporium extracts were prepared by incubating the spore
suspension in 0.1M DTT, 0.05% SDS, and 0.1M NaCl, pH 10 for
2.5 h in a 37uC shaking water bath [27], or by a sonication in
20 mM Tris-HCl, 0.5 mM EDTA, pH 7.5. Sonication was
performed using a Microsonix XL ultrasonic cell disruptor
(Microson) for seven 1 min bursts (output power 12 W), each
separated by 2 min cooling on ice [28]. By centrifugation, spores
(exosporium negative) and supernatants were separated. The spore
pellets were washed twice with the spore binding buffer as
described above, and were subjected to PLG binding assays. For
ligand blot analysis, exosporium extracts or recombinant proteins
were run on 4–12% SDS-PAGE gel and then electrophoretically
transferred onto a nitrocellulose membrane. The membrane was
soaked in PBS/0.05 Tween 20 (PBST) containing 1% bovine
serum albumin overnight at 4uC to renature the proteins, and then
it was incubated with PLG (1 mg/ml in PBST/1% BSA) for 1.5 h
at room temperature. The membrane was washed 5 times with
PBST and incubated with anti-PLG antibody for 1 h followed by
the corresponding horseradish peroxidase (HRP)-conjugated
secondary antibody. The blot was visualized by HRP reaction.
PLG binding to recombinant receptors
MaxiSorp 96 well plates (Nunc) were coated overnight with
different concentrations of recombinant proteins (7.8–500 nM) at
4uC. Following 3 washings with PBST, wells were blocked for 1 h
at room temperature with 0.1% gelatin/PBS and then washed 3
times. Afterwards, 100 ml/well of human PLG (1 mg/ml) were
added and incubated for 2 h at room temperature. Unbound PLG
was removed by washing 3 times with PBST. Bound PLG was
incubated with anti-PLG antibody (1:5,000) for 1 h followed by
secondary antibody. PLG binding to receptors was colorimetri-
cally measured at 450 nm after sequential addition of a HRP
substrate TMB (3,39,5,59-tetramethylbenzidine) and sulfuric acid.
C3 deposition and degradation on spore surface
Spores (2610
7/well) were washed, resuspended in PBS, and
immobilized onto MaxiSorp microplates (Nunc) overnight at 4uC.
After washing with PBST, wells were blocked with PBS/0.2%
gelatin for 1 h at room temperature and incubated with 10% NHS
(100 ml) for 30 min at room temperature. The wells were washed 2
times with PBST and incubated with 2 mg/well of PLG for 1 h in
the presence or absence of protease cocktail (100-fold dilution,
Sigma). Bound PLG was activated by uPA (20 units/well) for 3 h
at 37uC. Deposited C3b was then detected by incubation with
anti-C3c antibody (1:2,000) followed by HRP-conjugated second-
ary antibody. C3 deposition was colorimetrically measured after
addition of TMB and sulfuric acid at 450 nm.
Preparation of rabbit BALF and phagocytosis assays
BALF was collected from New Zealand White rabbits infused
with 30–40 ml of Hanks’ balanced salt solution (HBSS) under the
approval of the Institutional Animal Care and Use Committee of
the Biocon (Rockville, MD; approval # A0900-09a). The BALF
was used after centrifuging at 1,500 rpm for 20 min at 4uC. For
macrophage phagocytosis assays, spores were incubated with
250 mg of BALF and/or 25 mg of NHS (as a source of C3) for 1 h
at room temperature in the presence or absence of 100 mM
leupeptin. Spores (8610
6) were washed twice with PBS and
resuspended in PBS. RAW264.7 cells were infected with the
spores at MOI of 10 and centrifuged to precipitate spores for
2 min. After 30 min of incubation, the cells were washed 6 times
with HBSS and lysed by 2.5% saponin, and phagocytosed spores
were counted by a serial dilution method on LB agar plate.
Protein staining and immunoblotting
Proteins were loaded onto 10% or 4–12% NuPAGE MES gel
(Invitrogen) and separated under reducing conditions (32 mM
dithiothreitol). Separated proteins were then silver-stained using
GelCode SilverSNAP kit (Pierce) according to manufacturer’s
instructions or immunoblotting. For immunoblotting, the separat-
ed proteins were electrophoretically transferred to a nitrocellulose
membrane using an iBlot gel transfer system (Invitrogen). After
blocking with 5% dried milk solution, the membrane was probed
with the primary antibody using PBST containing 5% milk, and
was incubated with the corresponding HRP-coupled secondary
antibody (1:10,000 dilution) for 1 h at room temperature. Then
the membrane was washed in PBST and visualized with the most
sensitive West Femto chemiluminescent substrate system (Thermo
Scientific).
Statistical analysis
P-values were calculated by the paired student’s t-test. Statistical
significance was determined by analysis of variance (ANOVA)
prior to Student’s t-test. Significance was set at P-values less than
0.05. Error bars in all the figures indicate standard error of the
mean (SEM) in a two-tailed t-test.
Results
Identification of human serum proteins interacting with
B. anthracis spores
Spores of the Sterne strain 34F2 were incubated with NHS.
After an extensive wash, the bound proteins were eluted by a
chaotropic solution followed by desalting. Desalted spore-bound
proteins were separated by 2D electrophoresis and visualized by
silver staining (Figure 1). Protein spots were excised from the gel
and trypsinized to be identified by LC-MS/MS (Table S1). The
identified proteins included complement, acute phase proteins,
and proteases. Among them, complement factor H and PLG were
relatively abundant spore-bound proteins (Figure 1B). To support
this finding, we trypsinized total eluted proteins from the spore
Innate Immune Evasion of B. anthracis
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S2, PLG and complements factor H and C3 were abundant
among the spore-bound proteins, with high numbers of peptide
hits and high peptide identification scores.
PLG binding to spores is exosporium-dependent
We further examined whether PLG binds to the spore surface of
B. anthracis using Western blotting. Purified PLG bound efficiently to
the sporesurface,whileplasmin showed moreefficientbindinginthe
NHS (Figure 2A), suggesting less existence of PLG in the NHS. To
examine whether PLG binding to the spores was exosporium-
dependent, we extracted exosporium of spores using an alkaline
buffer containing DTT-SDS-NaCl and sonication. To test for the
removal of exosporium proteins, we carried out Western blot
analysis with antibodies against BclA and GroEL, major exosporium
proteins. BclA and GroEL were efficiently extracted by both alkaline
solution and sonication (Figure 2B). The resulting exosporium-
negative spores were then subjected to the PLG binding assays.
Removal of exosporium revealed a significant decrease in PLG
binding onto the surfaces (Figure 2C). Nodetectable amount of PLG
was bound in the exosporium-negative, non-pathogenic B. subtilis as
well. Heat treatment of spores (65uC for 30 min) did not show a
significant change PLG binding (Figure 2D), suggesting heat-
insensitive receptor-mediated PLG binding. These data demonstrat-
ed that exosporium was involved in PLG binding to spores.
B. anthracis spore-bound PLG is functional
To examine whether PLG bound to pathogen receptors can be
activated to plasmin, spores were incubated with PLG and its
activator uPA. Spore-bound PLG was efficiently activated by uPA
in a concentration-dependent manner (Figure 3A). This PLG
binding to pathogen surface was abrogated by 50 mM of lysine
analogues such as arginine and 6-amino-n-caproic acid (6-ACA),
indicating that binding of PLG to spores was specific to the
presence of lysine residues in the spore surface proteins (Figure 3B).
To compare the binding specificity of PLG and plasmin, purified
enzymes were incubated with the spores. The amount of bound
proteins after elution and PLG activation by uPA was measured
using a colorimetric assay. The assay demonstrated a similar
affinity of the spores for PLG and plasmin, within less than
100 nM (Figure 3C).
Identification of the spore PLG receptors
To screen for the PLG receptors, exosporium extracts were
prepared in an alkaline buffer as described above and subjected to
a ligand blot analysis overlaid with PLG and probed with anti-
PLG antibody. The bands of silver-stained gel (Figure 4A)
corresponding to each PLG binding protein in a ligand blot
(Figure 4B) were excised from the gel and subjected to tryptic
digestion and peptide mass fingerprinting using a LTQ-tandem
MS/MS. Bands 1–3 were identified to be chaperonin-60 kDa
(GroEL), a-enolase, and translation elongation factor-tu (EF-tu),
respectively (Figure 4C). To further confirm the putative PLG
receptors in experiments with recombinant proteins, the genes of
the above proteins were PCR-amplified from a bacterial
chromosome using specific primers. The amplicons were inserted
into pTrcHis-TOPO vector to generate proteins and all
recombinant proteins were expressed in E. coli and purified
(Figure 5A). Strong PLG binding to a-enolase and EF-tu, but weak
binding to GroEL, was observed in a ligand blot assay (Figure 5B).
Binding affinity of recombinant receptors to PLG was further
determined in a microplate coated with different concentrations of
receptor proteins. PLG binding to the receptors was dose-
dependent and the affinity was in the order of a-enolase.EF-
tu.GroEL (Figure 5C). To further support the differential
binding, we conjugated beads (particle diameter of 1 mm) with
recombinant proteins to mimic spores. PLG was able to bind
strongly with a-enolase-conjugated beads and weakly with EF-tu-
congugated beads (Figure 5D). Together, these results suggest that
a-enolase and EF-tu are PLG receptors of B. anthracis spores.
Surface-bound PLG exhibits anti-opsonic activities
It has been known that upon complement activation, C3b,
along with cleavage products such as iC3b, is covalently attached
Figure 1. 2D gel analysis of human serum proteins interacting with B. anthracis Sterne spores. Proteins were eluted from NHS-treated
spores and separated by 2D electrophoresis. Proteins were visualized by silver staining and were identified by LTQ-MS/MS as described in Materials
and Methods. (A) Control eluates from spores alone without NHS. (B) Proteins eluted from NHS-treated spores by a chaotropic reagent. Protein
identifications by LTQ-tandem MS/MS were indicated in gel B.
doi:10.1371/journal.pone.0018119.g001
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pathogenesis [29,30]. To assess whether spore-bound PLG is able
to degrade C3b deposited on the surface, we performed a C3b
deposition and degradation assay based on whole-spore ELISA.
Spores were immobilized onto microplates and treated with NHS
and PLG. After extensive washing, spore-bound PLG was
activated by uPA, and deposition of C3b on the spore surface
was monitored. Spore-bound active plasmin led to a drastic
decrease in C3b molecules on the surface compared to control
without PLG activation by uPA, or those pretreated with PLG in
the presence of protease cocktail (Figure 6A). Plasmin-mediated
C3b degradation was confirmed by Western blot analysis after
incubation of C3b with plasmin-coated spores. Both a and b chain
of C3b were degraded by spore-coated plasmin, which was
inhibited by leupeptin treatment (Figure 6B). These suggest that
after its activation by uPA, spore surface-bound PLG exhibits anti-
opsonic activity by cleaving C3b molecules.
Rabbit BALF decreases complement-dependent
phagocytosis
In inhalation anthrax, the lung serves as a portal of entry. Before
alveolar macrophages phagocytose deposited spores, they may
interact with the BALF in the alveolar space. Therefore, we
examined whether the interaction with BALF increases or
decreases spore phagocytosis. When rabbit complements were
incubated with the BALF, degraded C3b fragment was detected in
Western blot with anti-C3 antibody, suggesting the existence of C3
degrading protein(s) (Figure 7A). To confirm the existence of PLG
and its binding to spores, spores were incubated with BALF and
the bound proteins were submitted to Western blot analysis with
anti-PLG antibody. As shown in Figure 7B, PLG in the rabbit
BALF bound to spores. To evaluate the role of spore-bound PLG
on the phagocytosis, we incubated B. anthracis spores with BALF
without activation of PLG by uPA in order to examine the intact
BALF effects. Murine macrophages RAW264.7 cells were then
infected with the spores in the presence of NHS. The macrophages
were lysed and the number of viable bacteria was determined by
counting CFU following dilution plating. Phagocytosis in the
presence of NHS alone increased the CFU 3-fold per well at
30 min post-infection and decreased the CFU per well in the
presence of NHS and BALF (Figure 7C). A decrease was observed
in the NHS only treated samples when leupeptin, a plasmin
inhibitor, was amended to the exposure media. Taken together,
PLG in the BALF may play a role in host defense in the lung.
Discussion
Following a proteomic approach, we have found that B. anthracis
spores bind a number of human serum proteins that are involved
in humoral and innate immunity. Spore-bound proteins included
complement proteins, blood coagulation/fibrinolysis regulators,
acute phase proteins, and cell surface and extracellular proteins.
Deposition of complement C3 onto B. anthracis spores has been
reported to be required for opsonin-dependent phagocytosis by
macrophages [21]. Inhaled pathogens such as Mycobacterium
tuberculosis [31,32] and Pseudomonas aeruginosa [33] were phagocy-
tosed by macrophages in a C3-dependent manner to be
subsequently cleared by the lungs. Although C3 opsonization of
pathogens including B. anthracis facilitates early infection steps
Figure 2. Binding of PLG to B. anthracis spores is exosporium-dependent. (A) Spores (1.6610
9) were incubated with PLG (10 mg) or NHS
(150 ml) and washed, and bound proteins were eluted by 3 M potassium thiocyanate. (A) Western blot of 5
th washed (W) and eluted (E) fractions with
anti-PLG antibody. Lane W demonstrates an absence of detectable protein in the last wash before elution. U indicates unbound proteins. PlaH and
PlaL represent heavy chain and light chain of plasmin, respectively. (B) Exosporium was removed by alkaline DTT-SDS-NaCl buffer or sonication as
described in Materials and Methods. Removal of exosporium was confirmed by Western blot analysis of major exosporium proteins BclA and GroEL.
(C) Exosporium-positive (NT), exosporium-negative (by alkaline extraction or sonication), or B. subtilis 168 spores were incubated with PLG and eluted
by a chaotropic reagent. Bound PLG was analyzed by Western blotting as described. U, unbound; W,5
th wash; and E, elution with a chaotropic salt.
(D) B. anthracis spores were incubated at 65uC for 30 min, and subjected to PLG binding assay as described above. No significant change of PLG
binding by heat treatment (65uC) was seen compared with no heat treated control (-).
doi:10.1371/journal.pone.0018119.g002
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apparently utilize diverse escape mechanisms. Our proteomic data
suggest that complement regulators are involved in control of
complement activation. Complement factor H, FHR-1, C1
inhibitor, and C4BP were acquired by B. anthracis spores (Table
S2). Complement factor H, a 150-kDa plasma glycoprotein, is the
central fluid-phase regulator of the alternative complement
pathway. Further study on complement factor H -mediated C3b
opsonization is warranted. In the present study, we focused on
whether spore-bound PLG regulates spore opsonization by C3b.
The results showed that spore-bound PLG induces a significant
decrease in C3b opsonization by uPA activation. Therefore, it is
likely that the acquisition of host regulators masks the pathogenic
surface, resulting in survival of B. anthracis spores. This might
represent a novel mechanism to inhibit the host innate immune
system during early B. anthracis infection.
Acquisition of PLG and its subsequent conversion to active
plasmin promote dissemination of bacteria in the host [34].
Several invasive bacterial pathogens utilize the PLG system to
invade tissues [16,35,36], and use of this system has been extended
to viruses [37] and parasites [38]. Increasing evidence proposes a
so-called ‘‘bacterial metastasis’’ that is facilitated by the binding
and activation of PLG and by the colonization and invasion of
PLG-bound bacteria into tissues [35].
As shown in this study, B. anthracis is capable of binding PLG on
the outer surface of spores. The bound PLG is activated to plasmin
by the addition of human activator uPA, promoting a surface-
associated plasmin activity. The binding and activation are
inhibited by the presence of the lysine analogue 6-ACA, suggesting
a lysine-dependent binding of PLG to spores. This supports the
existence of lysine binding sites in PLG, which has been shown for
several pathogens to be mediated by PLG kringle domains [39–
41]. This may account for the similar binding capacity to spore
receptors in spite of the conformational change by proteolytic
cleavage between the kringle and protease domains [42].
Heat-resistant spores of B. anthracis were retained in the lungs
of mice challenged with aerosolized Sterne spores for all infection
periods [43]. Unlike the lung, homogenates of other organs such
as lymph node, liver, and spleen showed the presence only of
vegetative bacilli in the same experiment [43]. Accordingly,
spores are the first cells of B. anthracis which invade through lung
barriers, and vegetative cells are the type that circulate in the
bloodstream and invade organs. The binding of host PLG or
plasmin might represent a mechanism to regulate several
physiological processes, e.g., fibrinolysis, ECM degradation, cell
migration, the processing of growth factors, and bacterial
metastasis into several organs [44].
The Gram-positive bacteria group A streptococci interact with
PLG via GAPDH and a–enolase on the surface [45,46].
Proteomic analysis of the PLG-binding proteins in the human
pathogen M. tuberculosis identified glutamine synthase A1, HSP70
(DnaK), HSP60 (groEL), EF-tu, and other proteins that are
metabolic proteins and are localized extracellularly [47–49]. In
our study, PLG-binding proteins of B. anthracis spores were
identified by ligand Western blotting of spore exosporium extracts
to be GroEL, a-enolase, and EF-tu. They are extracellularly
Figure 3. Spore-bound PLG is activated by uPA. (A) Plasmin activity of bound PLG after uPA activation. Spores (5610
7) were incubated with
PLG and washed, and 20 units of uPA and plasmin substrate VLK-pNA were added. After incubation for 15 min at room temperature, the absorbance
was measured at 405 nm. (B) Effect of lysine analogues on spore-bound PLG/plasmin activity. Spores (5610
7) were incubated with PLG (2 mg) in the
presence of 50 mM amino acids, and assayed as described in panel A. (C) Binding affinity of PLG and plasmin to spores. PLG and plasmin were
incubated with spores (2.4610
7) and the amount of bound proteins was assayed by the colorimetric method described in panel B. The amount of
plasmin was determined using a standard activity curve.
doi:10.1371/journal.pone.0018119.g003
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non-virulent B. subtilis has no exosporium, these PLG receptors
might not be localized in outmost surface of its spores resulting in
no PLG binding as shown in Figure 2. This could be a feature
characteristic of a virulent B. anthracis in contrast to a non-virulent
B. subtilis. The PLG binding to receptor proteins is usually
mediated by a carboxyl-terminal lysine residue. In a competition
assay, lysine and its analogue 6-ACA significantly inhibited PLG
binding to spores, suggesting that a lysine residue is involved in
PLG binding.
Figure 4. Identification of PLG receptors. Spore extracts obtained from an acidic buffer were separated on a 4–12% SDS-PAGE. (A) The proteins
were visualized by coomassie brilliant blue staining (CBB). (B) Far-Western (Ligand) blot with PLG. The proteins were transferred onto a nitrocellulose
membrane, and the membrane was incubated with PLG. PLG-bound proteins were visualized by Western blotting with anti-PLG antibody. (C)
Identification of proteins interacting with PLG. Bands (1–3) were excised from the gel and subjected to in-gel digestion with trypsin. LTQ-MS/MS was
performed to identify the proteins.
doi:10.1371/journal.pone.0018119.g004
Figure 5. PLG binding of recombinant receptors. (A) Recombinant proteins were expressed on plasmid pTrcHis2-TOPO by IPTG induction and
purified by Ni
+-chelate column chromatography. The purified proteins were visualized on SDS-PAGE by Coomassie blue staining. (B) Analysis of PLG
binding of recombinant receptors by ligand blot. The bound PLG was detected by anti-PLG antibody. (C) Analysis of PLG binding of recombinant
receptors by ELISA. Different concentrations of receptors were immobilized on a plate. After incubation with PLG (0.1 mg/well), binding activity was
analyzed by anti-PLG antibody antibody. &, enolase; m, EF-tu;N, GroEL; and #, control BSA. (D) PLG binding of receptor-conjugated beads.
Receptor-conjugated beads (50 ml) were incubated with PLG (1 mg) and eluted with 100 ml of 3 M potassium thiocyanate. The eluted protein (10 ml)
from the beads was analyzed by Western blotting with anti-PLG.
doi:10.1371/journal.pone.0018119.g005
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activation system, some pathogens present an endogenous PLG
activation system, e.g., streptokinase [50], staphylokinase [51], and
Pla [52]. B. anthracis secretes two major metalloproteases, Npr599
(or NprB) and InhA, that exhibit PLG-degrading activity [15].
However, proteolysis of PLG by these proteases did not display
plasmin activity [15]. This activity has been shown in the NprB
homologue bacillolysin MA, produced by B. megaterium, which
converts PLG into angiostatin and mini-PLG [53]. Another NprB-
like protease, aureolysin of S. aureus, has the ability to convert PLG
into angiostatin and mini-PLG and activates pro-uPA to uPA [54].
This observation opens up the possibility that in addition to the
host activation, B. anthracis-bound PLG may be activated by a
bacterial activation system such as pro-uPA activation by bacterial
proteases. Thus, whether PLG activation during B. anthracis
infection is due to secreted proteases, the host PLG activation
system, or both deserves further study.
Based on the above considerations, complement regulators from
bacterial pathogens could be vaccine candidates to fight bacterial
infections. For instance, GNA1870, a lipoprotein of Neisseria
meningitidis, was identified to be a complement factor H binding
protein and meningococcal vaccine candidate [55]. In animal
models, antibodies binding to GNA1870 inhibit binding of
complement factor H and thus render the bacterium susceptible
to the alternative complement pathway. Furthermore, the bound
antibodies activate the classical pathway, thereby initiating and
Figure 6. Degradation of deposited C3b by B. anthracis spores-bound PLG. (A) Spores (2610
7/well) were immobilized onto a microplate and
incubated with 10% NHS (100 ml) for 30 min at room temperature. Washed spores were incubated with 2 mg/well PLG for 1 h in the presence or
absence of protease cocktail. Bound PLG was activated by uPA (20 units/well) for 3 h at 37uC. Deposited C3b was detected by anti-C3c IgG and HRP-
conjugated secondary antibody followed by TMB reaction. C3b deposition is expressed as the mean absorbance at 450 nm of quadruplicates. Error
bars indicate 6 standard deviation. *P,0.001 (paired Student’s t-test). (B) Spores were incubated with plasmin and washed extensively as described
in Figure 2A. C3b was incubated with the spores in the presence or the absence of leupeptin and C3b degradation was analyzed by Western blot with
anti-C3c antibody.
doi:10.1371/journal.pone.0018119.g006
Figure 7. Rabbit BALF decreases spore phagocytosis of macrophages. (A) Rabbit complements were incubated with BALF (3 and 30 mg) in
the PBS for 1 h and subjected to Western blot analysis with anti-C3b antibody. Degradation of C3b was indicated by arrow (27 kDa of a93 chain). (B)
PLG in the BALF interacts with spores. BALF was incubated with spores, eluted by a chaotropic salt and subjected to Western blot analysis with anti-
rabbit PLG antibody. (C) BALF decreases NHS-mediated spore phagocytosis. RAW264.7 cells were infected with NHS-treated spores in the presence of
BALF and/or leupeptin. Phagocytosed spores were determined by a serial agar plating method.
doi:10.1371/journal.pone.0018119.g007
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regulators of complement C3b might be useful as additional
vaccine targets to avoid the immune evasion by the above
discussed mechanisms. A recent study showed that Streptococcus suis
enolase localizes on the cell surface and facilitates bacterial
adherence, and that enolase confers complete protection against
infection to mice [56]. Proteomic analysis showed that B. anthracis
expresses a-enolase as a dominant immunogenic antigen [57,58];
however, the function of enolase has not been established. Another
study demonstrated that B. anthracis glyceraldehydes-3-phosphate
was predominantly interacted with plasminogen and that
immunization with the recombinant protein resulted in a
significant protection upon challenge with B. anthracis in the
murine model [25]. Therefore, we propose that B. anthracis
proteins interacting with PLG (i.e. a-enolase) function as a
protective antigen and are vaccine candidates to inhibit innate
immune evasion by the pathogen.
In summary, we have shown that B. anthracis may utilize the host
PLG system to regulate complement opsonization in order to
evade innate immunity as reported elsewhere [17,31,35,59,60].
We have identified PLG as a spore-associating protein. PLG-
bound spores were capable of exhibiting anti-opsonic properties by
cleaving C3b molecules through the surface receptors a-enolase
and EF-tu. PLG-dependent anti-oposonization was confirmed in
the rabbit BALF by its C3b degradation and anti-phagocytic
activity. This suggests new avenues for development of anti-
opsonization agents with capacity in affecting innate immunity.
Supporting Information
Table S1 Identification of human serum proteins
interacting with B. anthracis spores separated by 2D
SDS-PAGE. Spore-bound serum proteins were separated onto
2D SDS-PAGE and the each spot excised from the gel was
subjected to LTQ-MS/MS.
(XLS)
Table S2 Identification of human serum proteins
interacting with B. anthracis spores. Spore-bound serum
proteins were subjected to LTQ-MS/MS. Percentage of wrong
identification was estimated to be ,2%, and #IDs $5 are listed.
#Peptides and #IDs represent the number of different peptides
detected from this protein and the total number of peptide
identifications from this protein, respectively.
(XLS)
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